Featured series 
Tag: Cancer
-
Nation & World
Research in brief
Major differences in protocols used to determine brain death; Harvard researchers achieve stem cell milestone; Consortium links chromosome abnormality to autism disorders; Blocking HIV infection; Oral osteoporosis meds appear to reduce the risk of jaw degradation; Six new genetic variants linked to heart-disease risk factor; Gene variation may elevate risk of liver tumor in some…
-
Nation & World
Damon Runyon Cancer Research Foundation awards fellowships
The Damon Runyon Cancer Research Foundation has named three Harvard affiliates among its 17 new fellows. The recipients of this prestigious, three-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country.
-
Nation & World
Cancer research pioneer Judah Folkman dies suddenly at 74
Cancer research pioneer Judah Folkman, the Andrus Professor of Pediatric Surgery and professor of cell biology at Harvard Medical School (HMS), died on Jan. 14 of a heart attack. Folkman, who was also the director of the Vascular Biology Program at Children’s Hospital Boston, was 74.
-
Nation & World
Cancer drug activates adult stem cells
The use of a drug used in cancer treatment activates stem cells that differentiate into bone appears to cause regeneration of bone tissue and be may be a potential treatment…
-
Nation & World
M. Judah Folkman, biomedical pioneer, dies at 74
One of Harvard Medical School’s (HMS) most forward-looking and innovative physician-scientists, M. Judah Folkman, died suddenly Monday (Jan. 14) after suffering a heart attack at the Denver International Airport in…
-
Nation & World
Gene variation may elevate risk of liver tumor in patients with cirrhosis
A genetic variation appears to significantly increase the risk that individuals with cirrhosis of the liver will develop hepatocellular carcinoma (HCC), a liver tumor that is the third leading cause…
-
Nation & World
Microchip-based device can detect rare tumor cells in bloodstream
A team of investigators from the Massachusetts General Hospital (MGH) BioMicroElectroMechanical Systems (BioMEMS) Resource Center and the MGH Cancer Center has developed a microchip-based device that can isolate, enumerate and…
-
Nation & World
Newly discovered type of cell death may end up inhibiting tumor growth
Sometimes healthy cells commit suicide. In the 1970s, scientists showed that a type of programmed cell death called apoptosis plays a key role in development, and the 2002 Nobel Prize in physiology or medicine recognized their work. As apoptotic cells degrade, they display standard characteristics, including irregular bulges in the membrane and nuclear fragmentation.
-
Nation & World
Blood stem cell’s roles could help clarify pathogenesis
No other stem cell is more thoroughly understood than the blood, or hematopoietic, stem cell. These occasional and rare cells, scattered sparingly throughout the marrow and capable of replenishing an entire blood system, have been the driving force behind successful bone marrow transplants for decades. Scientists, for the most part, have seen this as the…
-
Nation & World
Consumption of some foods associated with decrease in ovarian cancer risk
New research from the Channing Laboratory at Brigham and Women’s Hospital (BWH) reports that frequent consumption of foods containing the flavonoid kaempferol, including non-herbal tea and broccoli, was associated with…
-
Nation & World
Flavonoid-rich diet helps women decrease risk of ovarian cancer
New research out of the Channing Laboratory at Brigham and Women’s Hospital (BWH) reports that frequent consumption of foods containing the flavonoid kaempferol, including nonherbal tea and broccoli, was associated with a reduced risk of ovarian cancer. The researchers also found a decreased risk in women who consumed large amounts of the flavonoid luteolin, which…
-
Nation & World
Obesity linked to higher prostate cancer mortality
Men who are overweight or obese when diagnosed with prostate cancer are at greater risk of death after treatment, according to a new study in the Dec. 15 issue of Cancer, a peer-reviewed journal of the American Cancer Society.
-
Nation & World
Obesity and overweight linked to higher prostate cancer mortality
Men who are overweight or obese when diagnosed with prostate cancer are at greater risk of death after treatment, according to a new study in the December 15, 2007 issue…
-
Nation & World
Flavonoid-rich diet helps women decrease risk of ovarian cancer
New research out of the Channing Laboratory at Brigham and Women’s Hospital (BWH) reports that frequent consumption of foods containing the flavonoid kaempferol, including nonherbal tea and broccoli, was associated with a reduced risk of ovarian cancer.
-
Nation & World
Genome study charts genetic landscape of lung cancer
An international team of scientists Sunday (Nov. 4) announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world’s leading cause of cancer deaths.
-
Nation & World
Study paints genetic portrait of lung cancer
An international team of scientists today announced the results of a systematic effort to map the genetic changes underlying lung cancer, the world’s leading cause of cancer deaths. Appearing in…
-
Nation & World
Newsmakers
Visiting scientist Frederick “Skip” Burkle, a senior fellow at the Harvard Humanitarian Initiative (HHI), was recently elected to the Institute of Medicine (IOM). New York Times columnist Maureen Dowd will deliver the Theodore H. White Lecture on Press and Politics Thursday (Oct. 25) at 6 p.m. in the John F. Kennedy Jr. Forum at the…
-
Nation & World
Hormone therapy for prostate cancer puts heart at risk
Administering androgen deprivation therapy (ADT) prior to surgery and combining ADT with radiation therapy are popular approaches to treating men diagnosed with advanced or high-risk localized prostate cancer. However, the potentially negative side effects of ADT are just now being explored. Researchers at Brigham and Women’s Hospital (BWH) have found that ADT may increase the…
-
Nation & World
Newsmakers
It was announced Wednesday (Oct. 10) that the prestigious 2007 IZA Prize in Labor Economics goes to Harvard’s Richard B. Freeman. He was praised by the Institute for the Study of Labor (IZA) in Germany for “fundamental contributions that have monumentally shaped modern labor economics.”
-
Nation & World
Harvard researchers find longevity, restricted diet link
Researchers believe they’ve found the cellular link between extremely restricted diets and dramatically lengthened lifespan and hope to use the knowledge to develop new treatments for age-related diseases.
-
Nation & World
Global momentum for smoke-free society
In a perspective article in the April 12 issue of The New England Journal of Medicine (NEJM), researchers from the Harvard School of Public Health (HSPH) and the Association of European Cancer Leagues describe the growing momentum for indoor smoking bans in countries across the globe. They identify Ireland’s pioneering 2004 comprehensive indoor smoking ban…
-
Nation & World
Daffodil Days, Harvard collect record amount
Consistently one of New England’s top sellers for the American Cancer Society’s annual Daffodil Days fundraiser, this year Harvard even managed to outdo itself. In this latest edition of the benefit, members of the University helped raise $45,843 to better every Harvard effort since the fundraiser’s inaugural run in 1988.
-
Nation & World
Vitamin D may protect against prostate cancer
With spring on the way, Harvard researchers advise men to get more sun, supplements, and seafood. All are good sources of vitamin D, and a large, lengthy study suggests the vitamin reduces risk of prostate cancer.
-
Nation & World
Brugge, colleagues urge Senate to increase NIH funding
Testifying Monday afternoon (March 19) before a U.S. Senate committee hearing on National Institutes of Health (NIH) funding, Harvard Medical School Cell Biology Department Chair Joan S. Brugge warned that “four years of flat [NIH] funding have had a devastating impact on the trajectory of cancer research,” threatening “the rapid progress in developing effective and…
-
Nation & World
Study questions ‘cancer stem cell’ hypothesis in breast cancer growth
A Dana-Farber Cancer Institute study challenges the hypothesis that “cancer stem cells” — a small number of self-renewing cells within a tumor — are responsible for breast cancer progression and recurrence, and that wiping out these cells alone could cure the disease.
-
Nation & World
Common prostate cancer therapy may carry risks
Androgen deprivation therapy – one of the most common treatments for prostate cancer – may increase the risk of death from heart disease in patients over age 65, according to a new study by researchers at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and other institutions.
-
Nation & World
Daffodil orders taken through tomorrow
Daffodil Days, one of the University’s most popular and colorful fundraisers, is accepting orders through Friday (March 2). Bouquets cost $7 each and include 10 stems. For $25, the bouquet includes a limited edition, collectible Boyds Bear teddy bear.
-
Nation & World
Still time to order daffodils, help American Cancer Society
Daffodil Days, one of the University’s most popular and colorful fundraisers, is now accepting orders from the Harvard community for the bright bouquets, which cost $7 each and include 10 stems. For $25, the bouquet includes a limited edition, collectible Boyds Bear teddy bear.
-
Nation & World
Practical way to target cancer cell mutations demonstrated
A study led by researchers at Dana-Farber Cancer Institute and Broad Institute of the Massachusetts Institute of Technology and Harvard University provides the first demonstration of a practical method of screening tumors for cancer-related gene abnormalities that might be treated with “targeted” drugs.
-
Nation & World
Study: Heed spiritual needs of cancer patients
People with advanced cancer felt they received little or no spiritual support from religious communities and the medical system, according to a new survey. However, those who did receive such support reported a better quality of life.